Nanoform Finland OYJ Logo

Nanoform Finland OYJ

Offers nanoparticle engineering services to enhance drug performance for pharma clients.

NANOFH | ST

Overview

Corporate Details

ISIN(s):
FI4000330972
LEI:
743700JJO2NU8LBS1592
Country:
Finland
Address:
Viikinkaari 4, FI-00790 HELSINKI

Description

Nanoform is a nanoparticle medicine enabling company that provides expert services in drug particle engineering to the global pharmaceutical and biotech industries. The company utilizes its proprietary, scalable Controlled Expansion of Supercritical Solutions (CESS®) technology to enhance the performance of both small and large molecule therapeutics. By creating uniform nanoparticles, Nanoform's services aim to improve drug bioavailability and solubility, enable higher drug loading in smaller dosage forms, and facilitate novel delivery routes such as subcutaneous, long-acting injectable, and inhaled formulations. The company partners with clients throughout the drug development lifecycle to overcome formulation challenges and reduce clinical trial attrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nanoform Finland OYJ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nanoform Finland OYJ

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nanoform Finland OYJ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Chong Kun Dang Pharmaceutical Corp. Logo
Develops and manufactures drugs for systemic anti-infectives and metabolic diseases.
South Korea
185750
CHOONG ANG VACCINE LABORATORY Logo
Develops and manufactures vaccines, pharmaceuticals, and feed additives for animals.
South Korea
072020
CHOSA Oncology AB Logo
Develops diagnostics and therapeutics for platinum-based chemotherapy.
Sweden
CHOSA
CHUGAI PHARMACEUTICAL CO., LTD. Logo
A research-driven pharmaceutical company developing innovative medical products.
Japan
4519
CHUKYOIYAKUHIN CO.,LTD. Logo
Offers health products and pharmaceuticals via a direct-to-home placement service.
Japan
4558
Cidara Therapeutics, Inc. Logo
Develops targeted immunotherapies and anti-infectives for serious diseases.
United States of America
CDTX
Cinclus Pharma Holding AB Logo
Clinical-stage pharma company developing a PCAB for gastric acid-related diseases.
Sweden
CINPHA
Cingulate Inc. Logo
A clinical-stage biopharma firm developing treatments for ADHD and anxiety.
United States of America
CING
CITIUS ONCOLOGY, INC. Logo
Biopharmaceutical company developing and commercializing targeted oncology therapies.
United States of America
CTOR
Citius Pharmaceuticals, Inc. Logo
A late-stage biopharmaceutical company developing and commercializing critical care products.
United States of America
CTXR

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.